Development and validation of nomograms predicting survival in Chinese patients with triple negative breast cancer

Development and validation of nomograms predicting survival in Chinese patients with triple negative breast cancer

Abstract Background Triple negative breast cancer (TNBC) is an aggressive and heterogeneous disease. Nomograms predicting outcomes of TNBC are needed for risk management. Methods Nomograms were based on an analysis of 296 non-metastatic TNBC patients treated at Sun Yat-sen Memorial Hospital from 200...

Full description

Bibliographic Details
Main Authors:	Yaping Yang, Ying Wang, Heran Deng, Cui Tan, Qian Li, Zhanghai He, Wei Wei, Enxiang Zhou, Qiang Liu, Jieqiong Liu
Format:	Article
Language:	English
Published:	BMC 2019-06-01
Series:	BMC Cancer
Subjects:	Nomograms Disease-free survival Overall survival Triple negative breast cancer Stromal tumor-infiltrating lymphocytes
Online Access:	http://link.springer.com/article/10.1186/s12885-019-5703-4

Similar Items

Construction and Validation of Nomograms Predicting Survival in Triple-Negative Breast Cancer Patients of Childbearing Age
by: Xiang Cui, et al.
Published: (2021-02-01)

A novel conditional survival nomogram for monitoring real-time prognosis of non-metastatic triple-negative breast cancer
by: Xiangdi Meng, et al.
Published: (2023-02-01)

Development and validation of nomograms for predicting overall and breast cancer-specific survival among patients with triple-negative breast cancer
by: Guo LW, et al.
Published: (2018-11-01)

A Risk Stratification Model for Predicting Overall Survival and Surgical Benefit in Triple-Negative Breast Cancer Patients With de novo Distant Metastasis
by: Zheng Wang, et al.
Published: (2020-01-01)

Prognostic Factors and Models for Elderly (≥70 Years Old) Primary Operable Triple-Negative Breast Cancer: Analysis From the National Cancer Database
by: Zhuowei Tang, et al.
Published: (2022-03-01)

A Nomogram to Predict Disease-Free Survival Following Neoadjuvant Chemotherapy for Triple Negative Breast Cancer
by: Meizhen Zhu, et al.
Published: (2021-10-01)

A Combined Nomogram Model to Predict Disease-free Survival in Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy
by: Bingqing Xia, et al.
Published: (2021-11-01)

A risk stratification model for predicting brain metastasis and brain screening benefit in patients with metastatic triple‐negative breast cancer
by: Mingxi Lin, et al.
Published: (2020-11-01)

The Development and Validation of a Nomogram Incorporating Clinical, Pathological, and Therapeutic Features to Predict Overall Survival in Patients With Penile Cancer: A SEER-Based Study
by: Ruidan Li, et al.
Published: (2022-04-01)

Nomogram predict relapse-free survival of patients with thymic epithelial tumors after surgery
by: Yang-Yu Huang, et al.
Published: (2021-07-01)

Construction and validation of a nomogram model for predicting the overall survival of colorectal cancer patients
by: Guo Peiyuan, et al.
Published: (2023-06-01)

Nomograms for predicting overall survival and cancer-specific survival in patients with surgically resected intrahepatic cholangiocarcinoma
by: Ma K, et al.
Published: (2019-07-01)

Triple-Negativity Identifies a Subgroup of Patients with Better Overall Survival in Essential Thrombocythemia
by: Marco Santoro, et al.
Published: (2022-08-01)

THE MAIN PARAMETERS OF CELLULAR IMMUNITY IN PATIENTS WITH TRIPLE-NEGATIVE BREAST CANCER: RELATIONSHIP WITH EFFICIENCY OF CHEMOTHERAPY
by: A. I. Chertkova, et al.
Published: (2018-11-01)

Prognostic nomograms to predict overall survival and cancer‐specific survival in patients with pelvic chondrosarcoma
by: Li Chen, et al.
Published: (2019-09-01)

Evaluating overall survival and competing risks of survival in patients with early‐stage breast cancer using a comprehensive nomogram
by: Yan‐Bo Xu, et al.
Published: (2020-06-01)

A nomogram based on peripheral lymphocyte for predicting 8-year survival in patients with prostate cancer: a single-center study using LASSO-cox regression
by: Jiayi Chen, et al.
Published: (2024-02-01)

Nomograms for Predicting Overall Survival Among Patients with Craniopharyngiomas at Initial Diagnosis: A SEER Population-Based Analysis
by: Teng H, et al.
Published: (2021-07-01)

Trophoblast cell-surface antigen 2 (TROP2) expression in triple-negative breast cancer
by: Yeonjin Jeon, et al.
Published: (2022-09-01)

Nomogram for individually predicting overall survival in rectal neuroendocrine tumours
by: Xingyu Feng, et al.
Published: (2020-09-01)

Nomogram application to predict overall and cancer-specific survival in osteosarcoma
by: Zheng W, et al.
Published: (2018-11-01)

A genomic-clinicopathologic nomogram for predicting overall survival of hepatocellular carcinoma
by: Kena Zhou, et al.
Published: (2020-12-01)

The Functional Impact of Alternative Splicing on the Survival Prognosis of Triple-Negative Breast Cancer
by: Sijia Wu, et al.
Published: (2021-01-01)

Triple-Negative Breast Cancer Survival in Iranian Patients
by: Mahdi Aghili, et al.
Published: (2013-08-01)

The relationship between immediate postmastectomy reconstruction modalities and survival benefits in patients with triple negative breast cancer
by: Luyao Dai, et al.
Published: (2023-02-01)

Development and validation of a nomogram for predicting the overall survival of patients with testicular cancer
by: Haohui Yu, et al.
Published: (2023-07-01)

Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer
by: Yifan Feng, et al.
Published: (2021-04-01)

Overall survival in patients over 40 years old with surgically resected pancreatic carcinoma: a SEER-based nomogram analysis
by: Jian Li, et al.
Published: (2019-07-01)

Triple negative breast cancer: 5-year results of combined treatment
by: Valerijus Ostapenko, et al.
Published: (2014-02-01)

Negative Relationship between Post-Treatment Stromal Tumor-Infiltrating Lymphocyte (TIL) and Survival in Triple-Negative Breast Cancer Patients Treated with Dose-Dense Dose-Intense NeoAdjuvant Chemotherapy
by: Sylvie Giacchetti, et al.
Published: (2022-03-01)

A nomogram for predicting overall survival in patients with Ewing sarcoma: a SEER-based study
by: Zhenggang Zhou, et al.
Published: (2020-11-01)

The therapeutic and prognostic role of cuproptosis-related genes in triple negative breast cancer
by: Bingye Shi, et al.
Published: (2023-05-01)

Effect of surgical treatment on patients with stage T3 or T4 triple-negative breast cancer: a SEER-based retrospective observational study
by: Jie Hu, et al.
Published: (2023-05-01)

A novel nomogram based on cardia invasion and chemotherapy to predict postoperative overall survival of gastric cancer patients
by: Hanjun Mo, et al.
Published: (2021-08-01)

Nomograms for Predicting Hepatocellular Carcinoma Recurrence and Overall Postoperative Patient Survival
by: Lidi Ma, et al.
Published: (2022-02-01)

Development and Validation of a nomogram for forecasting survival of alcohol related hepatocellular carcinoma patients
by: Tao Yan, et al.
Published: (2022-11-01)

A clinical variable‐based nomogram could predict the survival for advanced NSCLC patients receiving second‐line atezolizumab
by: Xiaoling Shang, et al.
Published: (2021-09-01)

Clinicopathological Features and Survival Outcomes of Metaplastic Breast Carcinoma – An Observational Multi-Centric Study
by: Sherwani M, et al.
Published: (2023-03-01)

Establishment of Prognostic Nomograms for Predicting the Survival of HR-Positive, HER2-Negative Metastatic Breast Cancer Patients Treated with Everolimus
by: Duan F, et al.
Published: (2021-08-01)

THE ROLE OF TUMOR-INFILTRATING LYMPHOCYTES IN TRIPLE NEGATIVE BREAST CANCER
by: Anca Zgura, et al.
Published: (2018-09-01)